Cannvas Data Analytics Creates Valuable Customer Insights
TORONTO, Nov. 27, 2018 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM), a leading digital cannabis educator and business technology company, is pleased to report over one million cannabis consumer data points have been collected since the launch of its digital cannabis education platform. The Cannvas.Me education platform uses artificial intelligence to contextualize and adapt to its users as they navigate its education platform, ensuring a best-in-class experience while collecting valuable industry and customer data points. Cannvas Data (Cannvas MedTechs Advanced Analytics division) uses the same advanced technology to closely analyze and process data points to reveal highly focused and relevant cannabis industry insights.
"What sets us apart is our ability to truly understand the power of cannabis data due to extensive backgrounds of using data as a framework for CRM and pharma programs," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "Our team has decades of experience building these platforms in the CPG, financial and pharma industries, and we are proud to report a fantastic response to the launch of Cannvas.Me. It is clear that cannabis consumers value our independence and our unbiased physician-backed content, and with each visit we gain important consumer data that contributes to the Cannvas database. We look forward to the continued rapid growth in website traffic as we add new and dynamic education modules and sign value-added partnerships with leading cannabis companies."
Cannvas.Me is an unbiased educational resource for medicinal and adult-use cannabis users offering innovative tools and physician-backed content to audiences wishing to learn about health care through cannabis.
Launched in 2018, the site now includes a number of modules highlighting the benefits of cannabis:
- Cannvas Academy - educational learning modules created by licensed medical practitioners and certified educators with a focus on health care, lifestyle and wellness;
- Cannvas Strain Matcher - an interactive experience where users learn which strain is best for alleviating specific ailments;
- Cannvas Culinary - a culinary training module with recipes, ideas and more;
- Cannvas Health & Fitness - combining a cannabis-healthy lifestyle with training and fitness activities;
- Cannvas Cannabis & Science - for active and potential cannabis users interested in learning more about the science of the plant and how it impacts the human endocannabinoid system.
Additional relevant modules and tools will be added to the platform as they become available.
About Cannvas Data
Pioneering to be the census data of the cannabis industry, Cannvas Data couple's machine learning algorithms with scientific and medical research data to provide meaningful insights to the global cannabis community. For more information visit: www.cannvasdata.com.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.